The added value of SPECT-CT in the detection of heterotopic ossification on bone scintigraphy.

PURPOSE: Heterotopic ossification (HO) is the abnormal osteogenesis in non-skeletal tissue. It can be difficult to detect, as it can mimic other conditions clinically and on imaging studies. The purpose of this study was to find the added value of SPECT-CT in accurate detection of HO. MATERIALS AND METHODS: A total of 1780 reports on the PACS system of patients underwent bone scintigraphy at the Department of Nuclear Medicine and were filtered for the term "HO" or "heterotopic bone formation" and "SPECT-CT". Thirty-four patients fulfilled this criterion. All patients had bone scintigraphy and SPECT/CT in the same occasion. Images were reviewed by two nuclear medicine physicians blindly. The certainty of the presence of extra-skeletal soft tissue ossification on the planar with SPECT was graded as "definitely present", "maybe present", or "not present", and the same was determined on planar with SPECT-CT images. RESULTS: Based on SPECT/CT, 23 (67.6%) patients were found to have HO, and 11 (32.4%) did not have confirming findings. Of the 23 positive patients on SPECT/CT, eight (34.8%) showed "definitely present" and 12 (52.2%) patients were under "maybe present" on SPECT only. Three (13%) patients were negative on the SPECT and showed evidence of HO on CT. Of the 11 patients that did not demonstrate definite evidence of HO on SPECT/CT, seven (63.6%) were negative on SPECT alone and, four (36.4%) were under "maybe present" on SPECT. The definite detection of HO was statistically significant higher when CT is added to SPECT. CONCLUSIONS: Our findings suggest that adding the CT component to SPECT is valuable in the detection of HO.

Reporting quality in systematic reviews of in vitro studies: a systematic review.

Background: Systematic reviews (SRs) and/or meta-analyses of in vitro research have an important role in establishing the foundation for clinical studies. In this study, we aimed to evaluate the reporting quality of SRs of in vitro studies using the PRISMA checklist.Method: Four databases were searched including PubMed, Virtual Health Library (VHL), Web of Science (ISI) and Scopus. The search was limited from 2006 to 2016 to include all SRs and/or meta-analyses (MAs) of pure in vitro studies. The evaluation of reporting quality was done using the PRISMA checklist.Results: Out of 7702 search results, 65 SRs were included and evaluated with the PRISMA checklist. Overall, the mean overall quality score of reported items of the PRISMA checklist was 68%. We have noticed an increasing pattern in the numbers of published SRs of in vitro studies over the last 10 years. In contrast, the reporting quality was not significantly improved over the same period (p = .363). There was a positive but not significant correlation between the overall quality score and the journal impact factor of the included studies.Conclusions: The adherence of SRs of in vitro studies to the PRISMA guidelines was poor. Therefore, we believe that using reporting guidelines and journals paying attention to this fact will improve the quality of SRs of in vitro studies.

Comparison of pinhole and high-resolution parallel-hole imaging for nodular thyroid disease.

INTRODUCTION AND OBJECTIVE: Pinhole has been the main standard collimator to be used for thyroid imaging. There has been a gradually increasing trend to replace pinhole with the use of high-resolution low-energy parallel-hole collimator with zoom in thyroid imaging. The objective of this study is to compare parallel-hole collimator acquisition of thyroid gland with that obtained by pinhole collimator to find the effect on the diagnostic information in nodular thyroid disease. MATERIAL AND METHODS: A total of 29 patients, 24 women and 5 men, aged 18 to 70 years who were routinely referred for thyroid imaging for the assessment of nodular disease were studied. Each patient was injected with 185 MBq (5 mCi) of Tc-99m sodium pertechnetate intravenously. After 20 minutes, acquisition using pinhole followed by parallel-hole collimators was obtained. For pinhole acquisition, a 3-mm insert was used, and 3 images were obtained in the anterior and anterior oblique projections. For parallel-hole acquisition, anterior view was obtained for 250 K. The collimator was placed as close as possible to the patient. The image quality, number, and definition of nodules were evaluated by 2 independent, qualified nuclear medicine physicians. Differences were resolved by consensus. RESULTS: There were 14 patients who had nodular patterns and 15 had no apparent nodules. There were 40 nodules of different sizes detected by pinhole imaging. Only 10 (25%) of these nodules were observed on parallel-hole images. CONCLUSION: Pinhole imaging must be used for thyroid imaging particularly in patients suspected of having nodular disease.

Impact of obesity on nuclear medicine imaging.

Obesity, with its alarming increase among adults and children, represents a significant health problem with serious medical, social, psychologic, and economic reverberations. The burden of this problem significantly affects the medical care system, including medical imaging. The effect of obesity on nuclear medicine imaging spans many aspects, from preimaging patient preparation to radiotracer administration, image acquisition, and image interpretation. The acquired images may be suboptimal because of artifacts due to soft-tissue attenuation and incomplete whole-body coverage, and quantification may be suboptimal, especially for PET. Other difficulties include mechanical problems such as the weight limit of the imaging table and the bore size of the PET or SPECT/CT scanner and the need to alter the timing, duration, or protocol of many imaging procedures. These issues are discussed in this review, which clarifies the impact of this epidemic health problem on nuclear medicine services and proposes possible solutions to overcome obesity-related difficulties encountered in nuclear medicine practice.